ACCENDRA HEALTH INC/VA/ entered into Commitment and Consent Letter with certain institutions that are holders of the 4.500% Senior Notes due 2029 and 6.625% Senior Notes due 2030, lenders under the Term Loan Credit Agreement, and lenders under the Existing Revolving Credit Facility Agreement (effective 2026-05-11).
“On May 11, 2026, Accendra Health, Inc. (the “ Company ”) entered into a Commitment and Consent Letter (the “ Commitment Letter ”) with certain institutions that are (a)(i) holders of the Company’s 4.500% Senior Notes due 2029 (the “ 2029 Notes ”) and 6.625% Senior Notes due 2030 (the “ 2030 Notes ” and, together with the 2029 Notes, the “ Existing Notes ”), collectively holding approximately all of the outstanding principal amount of the 2029 Notes and approximately 83% of the outstanding principal amount of the 2030 Notes as of May 11, 2026 and (ii) lenders under the Company’s existing Term Loan Credit Agreement (as defined below) (collectively, the “ Commitment and Consenting Parties ” and each, a “ Commitment and Consenting Party ”), (b) certain lenders under the Company’s existing Term Loan Credit Agreement consenting solely with respect to the Term B-1 Term Loan Consent (as defined below) (the “ Term B-1 Term Loan Consenting Parties ”) and (c) all lenders under the Company’s Exist”
Earnings Releases
ACCENDRA HEALTH INC/VA/ reported the first quarter ended March 31, 2026 results: revenue $ 627.8, net income $ (6.5), EPS $ (0.08).
“Commission this morning. Details on First Quarter 2026 Results First Quarter Results (1) ($ in millions, except per share data) 1Q26 1Q25 Net Revenue $ 627.8 $ 673.9 Loss from continuing operations, net of tax, GAAP $ (6.5) $ (3.8) Adj. net (loss) income from continuing operations, Non-GAAP $ (3.1) $ 23.2 ”
Governance Changes
ACCENDRA HEALTH INC/VA/: Filed articles of amendment to certificate of incorporation to change corporate name (effective 2025-12-24).
“On December 24, 2025, the Company filed articles of amendment to its certificate of incorporation (the “ Articles of Amendment ”) and amended its bylaws (the “ Second Amended and Restated Bylaws ”) to change the corporate name set forth therein from “Owens & Minor, Inc.” to “Accendra Health, Inc.””
Governance Changes
ACCENDRA HEALTH INC/VA/: Amended bylaws to change corporate name from Owens & Minor, Inc. to Accendra Health, Inc (effective 2025-12-24).
“On December 24, 2025, the Company filed articles of amendment to its certificate of incorporation (the “ Articles of Amendment ”) and amended its bylaws (the “ Second Amended and Restated Bylaws ”) to change the corporate name set forth therein from “Owens & Minor, Inc.” to “Accendra Health, Inc.””
Material Agreements
ACCENDRA HEALTH INC/VA/ amended Amended & Restated Receivables Purchase Agreement with PNC Bank, National Association, PNC Capital Markets LLC valued at $150 million.
“On the Closing Date, O&M Funding LLC (“ O&M Funding ”), as Seller, and Byram Healthcare Centers, Inc. (“ Byram ”), as initial Servicer, each a wholly-owned subsidiary of the Company, entered into an Amended & Restated Receivables Purchase Agreement (the “ Amended & Restated Receivables Purchase Agreement ”) with persons from time to time party thereto, as Purchasers, PNC Bank, National Association (“ PNC ”), as Administrative Agent, and PNC Capital Markets LLC, as Structuring Agent, pursuant to which accounts receivable with an aggregate outstanding amount not to exceed $150 million are sold”
Debt Financings
ACCENDRA HEALTH INC/VA/ incurred debt of aggregate outstanding amount not to exceed $150 million with PNC Bank, National Association maturing Scheduled Termination Date of October 18, 2027.
“On the Closing Date, O&M Funding LLC (“ O&M Funding ”), as Seller, and Byram Healthcare Centers, Inc. (“ Byram ”), as initial Servicer, each a wholly-owned subsidiary of the Company, entered into an Amended & Restated Receivables Purchase Agreement (the “ Amended & Restated Receivables Purchase Agreement ”) with persons from time to time party thereto, as Purchasers, PNC Bank, National Association (“ PNC ”), as Administrative Agent, and PNC Capital Markets LLC, as Structuring Agent, pursuant to which accounts receivable with an aggregate outstanding amount not to exceed $150 million are sold, on a limited-recourse basis, to the Purchasers in exchange for cash (the “ Receivables Sale Program ”).”
M&A Transactions
ACCENDRA HEALTH INC/VA/ completed a disposition involving Dominion Healthcare Acquisition Corporation and Dominion Healthcare Holdings, L.P. for $375 million in cash (closed 2025-12-31).
“effect to the completion of certain reorganization transactions, comprises the “ Products & Healthcare Services ” or “ P&HS ” business of the Company), for an aggregate of $375 million in cash, subject to certain adjustments for cash, indebtedness, net working capital and transaction expenses (the “ Sale ”) and (ii) contributed, assigned, transferred and”
Debt Financings
ACCENDRA HEALTH INC/VA/ faced acceleration on senior notes of $1,000,000,000 aggregate principal amount with Regions Bank at 10.000% maturing due 2030.
“of April 4, 2025, by and among the Company, the guarantors named therein and Regions Bank, as trustee and as collateral agent (the “Indenture”), under which the Company issued $1,000,000,000 aggregate principal amount of 10.000% Senior Secured Notes due 2030 (the “Notes”), the Company is required to redeem such Notes. On June 5, 2025, the Company issued a notice of”
Jonathan A. Leon was appointed as Executive Vice President, Chief Financial Officer at ACCENDRA HEALTH INC/VA/.
“On September 23, 2024, Owens & Minor, Inc. (the “Company”) announced that Jonathan A. Leon, age 58, has been appointed Executive Vice President, Chief Financial Officer of the Company, effective September 23, 2024.”
Jonathan A. Leon was appointed as Interim Chief Financial Officer at ACCENDRA HEALTH INC/VA/.
“Jonathan A. Leon, the Company’s Senior Vice President, Corporate Treasurer, has been appointed as interim Chief Financial Officer effective June 21, 2024.”
Alexander J. Bruni resigned as Executive Vice President & Chief Financial Officer at ACCENDRA HEALTH INC/VA/.
“Alexander J. Bruni, the Company’s Executive Vice President & Chief Financial Officer, has, at the request of the Company, resigned from his position as an officer of the Company, effective June 21, 2024.”
Jennifer Stone was named as Executive Vice President & Chief Human Resources Officer at ACCENDRA HEALTH INC/VA/.
“On May 24, 2024, Owens & Minor, Inc. (the Company) named Jennifer Stone (53) Executive Vice President & Chief Human Resources Officer of the Company effective June 3, 2024.”
Shareholder Votes
ACCENDRA HEALTH INC/VA/ shareholders approved Advisory vote to approve the compensation of our named executive officers at the 2024-05-09 meeting.
“2023 Omnibus Incentive Plan, as follows: Votes Votes For Votes Against Abstentions Broker Non- Votes 64,181,423 3,371,256 52,817 3,113,777 (4) Advisory vote to approve the compensation of our named executive officers as follows: Votes Votes For Votes Against Abstentions Broker Non- Votes 66,163,767 1,381,531 60,198 3,113,777 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.”
Shareholder Votes
ACCENDRA HEALTH INC/VA/ shareholders approved Approval of Amendment No. 1 to the Owens & Minor, Inc. 2023 Omnibus Incentive Plan at the 2024-05-09 meeting.
“(3) Approval of Amendment No. 1 to the Owens & Minor, Inc. 2023 Omnibus Incentive Plan”
Shareholder Votes
ACCENDRA HEALTH INC/VA/ shareholders approved Ratification of KPMG LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2024 at the 2024-05-09 meeting.
“(2) Ratification of KPMG LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2024”
Shareholder Votes
ACCENDRA HEALTH INC/VA/ shareholders approved Election of nine directors, each for a one-year term at the 2024-05-09 meeting.
“ (1) Election of nine directors, each for a one-year term, as follows: Director Votes For Votes Against Abstentions Broker Non- Votes Mark A.”
Snehashish Sarkar was named as Executive Vice President & Chief Information Officer at ACCENDRA HEALTH INC/VA/.
“On May 9, 2024 Owens & Minor, Inc. (the Company) named Snehashish Sarkar (49) Executive Vice President & Chief Information Officer of the Company.”
Earnings Releases
ACCENDRA HEALTH INC/VA/ reported the first quarter ended March 31, 2024 results: revenue $2.6 billion, net income $(0.29) per share.
“VA – May 3, 2024 – Owens & Minor, Inc. (NYSE: OMI) today reported financial results for the first quarter ended March 31, 2024. Key Highlights: ● Consolidated revenue of $2.6 billion in the first quarter, representing year-over-year growth of 4% ● GAAP operating margin was flat while adjusted operating margin expanded by 31 basis points versus prior year ●”
Dan J. Starck retired as Executive Vice President, Business Excellence at ACCENDRA HEALTH INC/VA/.
“On April 16, 2024, Dan J. Starck, Executive Vice President, Business Excellence of Owens & Minor, Inc. (the “Company”), informed the Company that he was retiring from his position at the Company, effective May 17, 2024.”
Earnings Releases
ACCENDRA HEALTH INC/VA/ reported the fourth quarter and year ended December 31, 2023 results: revenue $10.3 billion, net income Net loss per common share of $(0.54) and adjusted net income per common share of $1.36.
“& Minor, Inc. (NYSE: OMI) today reported financial results for the fourth quarter and year ended December 31, 2023. Full Year 2023 Key Highlights: ● Consolidated revenue of $10.3 billion ● Delivered $741 million of operating cash flow ● Reduced total debt by $403 million and reduced net debt by $577 million ● Net loss per common share of $(0.54) and adjusted net”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.